BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ward JA, Yerke J, Lumpkin M, Kapoor A, Lindenmeyer CC, Bass S. Evaluation of a protocol for rifaximin discontinuation in critically ill patients with liver disease receiving broad-spectrum antibiotic therapy. World J Hepatol 2023; 15(11): 1226-1236 [PMID: 38075005 DOI: 10.4254/wjh.v15.i11.1226]
URL: https://www.wjgnet.com/1948-5182/full/v15/i11/1226.htm
Number Citing Articles
1
Lorenzo Ridola, Alessandro Mari. Rifaximin discontinuation during broad-spectrum antibiotic treatment in critically ill patients with hepatic encephalopathyWorld Journal of Hepatology 2024; 16(11): 1356-1360 doi: 10.4254/wjh.v16.i11.1356
2
Chien-Hao Huang, Piero Amodio. Can rifaximin for hepatic encephalopathy be discontinued during broad-spectrum antibiotic treatment?World Journal of Hepatology 2024; 16(2): 115-119 doi: 10.4254/wjh.v16.i2.115